SNSE — Sensei Biotherapeutics Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Sensei Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -36.8 | -48.6 | -34.1 | -30.2 | -21.1 |
| Depreciation | |||||
| Non-Cash Items | 5.73 | 7.21 | 5.06 | 4.65 | 2.08 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.117 | 1.01 | -4.33 | -0.489 | -1.59 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -30.3 | -39 | -32 | -24.7 | -20.5 |
| Capital Expenditures | -2.03 | -0.321 | -0.18 | -0.146 | -0.016 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -141 | 50.3 | 38.6 | 22.6 | 19.8 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -143 | 49.9 | 38.4 | 22.4 | 19.8 |
| Financing Cash Flow Items | 0.08 | 0.104 | -0.028 | 0.024 | 0.143 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 164 | -0.287 | -11.2 | -0.787 | -0.645 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9.44 | 10.6 | -4.78 | -3.02 | -1.33 |